Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study. J. Anal. Oncol. 2013;2(3): 128-134. doi:10.6000/1927-7229.2013.02.03.1